Literature DB >> 27920123

Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop.

Hema Viswambharan1, Nadira Y Yuldasheva2, Anshuman Sengupta2, Helen Imrie2, Matthew C Gage2, Natalie Haywood2, Andrew M N Walker2, Anna Skromna2, Natallia Makova2, Stacey Galloway2, Pooja Shah2, Piruthivi Sukumar2, Karen E Porter2, Peter J Grant2, Ajay M Shah2, Celio X C Santos2, Jing Li2, David J Beech2, Stephen B Wheatcroft2, Richard M Cubbon2, Mark T Kearney2.   

Abstract

RATIONALE: In the endothelium, insulin stimulates endothelial NO synthase (eNOS) to generate the antiatherosclerotic signaling radical NO. Insulin-resistant type 2 diabetes mellitus is associated with reduced NO availability and accelerated atherosclerosis. The effect of enhancing endothelial insulin sensitivity on NO availability is unclear.
OBJECTIVE: To answer this question, we generated a mouse with endothelial cell (EC)-specific overexpression of the human insulin receptor (hIRECO) using the Tie2 promoter-enhancer. METHODS AND
RESULTS: hIRECO demonstrated significant endothelial dysfunction measured by blunted endothelium-dependent vasorelaxation to acetylcholine, which was normalized by a specific Nox2 NADPH oxidase inhibitor. Insulin-stimulated phosphorylation of protein kinase B was increased in hIRECO EC as was Nox2 NADPH oxidase-dependent generation of superoxide, whereas insulin-stimulated and shear stress-stimulated eNOS activations were blunted. Phosphorylation at the inhibitory residue Y657 of eNOS and expression of proline-rich tyrosine kinase 2 that phosphorylates this residue were significantly higher in hIRECO EC. Inhibition of proline-rich tyrosine kinase 2 improved insulin-induced and shear stress-induced eNOS activation in hIRECO EC.
CONCLUSIONS: Enhancing insulin sensitivity specifically in EC leads to a paradoxical decline in endothelial function, mediated by increased tyrosine phosphorylation of eNOS and excess Nox2-derived superoxide. Increased EC insulin sensitivity leads to a proatherosclerotic imbalance between NO and superoxide. Inhibition of proline-rich tyrosine kinase 2 restores insulin-induced and shear stress-induced NO production. This study demonstrates for the first time that increased endothelial insulin sensitivity leads to a proatherosclerotic imbalance between NO and superoxide.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  diabetes mellitus; insulin; insulin resistance; reactive oxygen species; superoxide

Mesh:

Year:  2016        PMID: 27920123     DOI: 10.1161/CIRCRESAHA.116.309678

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

Review 1.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

Review 2.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Letter by Rask-Madsen et al Regarding Article, "Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop".

Authors:  Christian Rask-Madsen; Kyoungmin Park; Qian Li; George L King
Journal:  Circ Res       Date:  2017-02-17       Impact factor: 17.367

Review 4.  Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators.

Authors:  Samuel J Turvey; Martin J McPhillie; Mark T Kearney; Stephen P Muench; Katie J Simmons; Colin W G Fishwick
Journal:  RSC Med Chem       Date:  2022-02-21

5.  Role of glutamine and interlinked asparagine metabolism in vessel formation.

Authors:  Hongling Huang; Saar Vandekeere; Joanna Kalucka; Laura Bierhansl; Annalisa Zecchin; Ulrike Brüning; Asjad Visnagri; Nadira Yuldasheva; Jermaine Goveia; Bert Cruys; Katleen Brepoels; Sabine Wyns; Stephen Rayport; Bart Ghesquière; Stefan Vinckier; Luc Schoonjans; Richard Cubbon; Mieke Dewerchin; Guy Eelen; Peter Carmeliet
Journal:  EMBO J       Date:  2017-06-28       Impact factor: 11.598

6.  Endothelial Insulin Receptor Restoration Rescues Vascular Function in Male Insulin Receptor Haploinsufficient Mice.

Authors:  Anshuman Sengupta; Peysh A Patel; Nadira Y Yuldasheva; Romana S Mughal; Stacey Galloway; Hema Viswambharan; Andrew M N Walker; Amir Aziz; Jessica Smith; Noman Ali; Ben N Mercer; Helen Imrie; Piruthivi Sukumar; Stephen B Wheatcroft; Mark T Kearney; Richard M Cubbon
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

7.  Oscillatory Shear Stress Induces Oxidative Stress via TLR4 Activation in Endothelial Cells.

Authors:  Zhimei Wang; Feng Wang; Xiangquan Kong; Xiaofei Gao; Yue Gu; Junjie Zhang
Journal:  Mediators Inflamm       Date:  2019-06-17       Impact factor: 4.711

8.  Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage.

Authors:  Azhar Maqbool; Nicole T Watt; Natalie Haywood; Hema Viswambharan; Anna Skromna; Natalia Makava; Asjad Visnagri; Heba M Shawer; Katherine Bridge; Shovkat K Muminov; Kathryn Griffin; David J Beech; Stephen B Wheatcroft; Karen E Porter; Katie J Simmons; Piruthivi Sukumar; Ajay M Shah; Richard M Cubbon; Mark T Kearney; Nadira Y Yuldasheva
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-13       Impact factor: 4.249

9.  Differential associations of ankle and brachial blood pressures with diabetes and cardiovascular diseases: cross-sectional study.

Authors:  Hema Viswambharan; Chew Weng Cheng; Kirti Kain
Journal:  Sci Rep       Date:  2021-04-30       Impact factor: 4.379

10.  HSP22 suppresses diabetes-induced endothelial injury by inhibiting mitochondrial reactive oxygen species formation.

Authors:  Lingling Yu; Qian Liang; Weifang Zhang; Minqi Liao; Minghua Wen; Biming Zhan; Huihui Bao; Xiaoshu Cheng
Journal:  Redox Biol       Date:  2019-01-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.